Anondita Medicare Files Newspaper Publication for May 28 EGM Notice
Anondita Medicare Limited filed a Regulation 30 newspaper publication notice confirming its 01/2026-27 EGM advertisements were published on May 7, 2026, in Financial Express and Jansatta. The EGM, scheduled for May 28, 2026, via VC/OAVM, seeks shareholder approval for a preferential warrant issue of ₹29,12,70,000 to promoter Mr. Anupam Ghosh, material RPTs with a subsidiary and the Managing Director, a MOA amendment to include new product categories, and managerial remuneration revisions for key directors.
*this image is generated using AI for illustrative purposes only.
Anondita Medicare Limited has filed a newspaper publication notice with the National Stock Exchange of India Limited pursuant to Regulation 30 read with Schedule III, Regulation 47, and applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that advertisements relating to the dispatch of the EGM notice and e-voting information for its 01/2026-27 Extra-Ordinary General Meeting were published on May 7, 2026, in the Financial Express (English) and Jansatta (Hindi) newspapers. The EGM is scheduled to be held on Thursday, May 28, 2026, at 01:00 P.M. (IST) through Video Conferencing (VC) / Other Audio-Visual Means (OAVM).
Newspaper Publication Details
The regulatory filing was submitted by Bhawna Bisht, Company Secretary and Compliance Officer, on behalf of Anondita Medicare Limited. The publication confirms compliance with applicable listing regulations ahead of the scheduled EGM. The EGM notice and related information are also available on the company's website.
| Parameter: | Details |
|---|---|
| Publication Date: | May 7, 2026 |
| English Newspaper: | Financial Express |
| Hindi Newspaper: | Jansatta |
| EGM Date: | May 28, 2026 |
| EGM Time: | 01:00 P.M. (IST) |
| Mode: | Video Conferencing / OAVM |
| Filing Authority: | Bhawna Bisht, Company Secretary |
Preferential Issue of Warrants
The Board proposes to issue up to 2,85,000 convertible warrants to persons belonging to the promoter category on a preferential basis. The warrants will be issued at a price of ₹1,022 each, including a premium of ₹1,012, aggregating to a total issue size of ₹29,12,70,000. The sole proposed allottee is Mr. Anupam Ghosh, a promoter of the company.
The payment structure requires 25% of the warrant issue price, amounting to ₹7,28,17,500, to be paid at the time of subscription. The remaining 75%, totaling ₹21,84,52,500, is payable upon the exercise of the warrants. The warrants are convertible into fully paid-up equity shares with a face value of ₹10 each within a period of 18 months from the date of allotment. The relevant date for determining the floor price is April 27, 2026.
| S.No. | Name of Investor | Category | No. of Warrants Proposed | Amount (₹) |
|---|---|---|---|---|
| 1. | Mr. Anupam Ghosh | Promoter | 2,85,000 | 29,12,70,000 |
The proceeds from the issue are intended to be utilized for capital expenditure, infrastructure development, and marketing activities. The company states that the issue will not result in any change in control or management.
Related Party Transactions
Shareholders will also consider resolutions for material related party transactions for the financial year 2026-27. The company seeks approval to enter into transactions with Anondita Healthcare & Rubber Products (India) Limited, a subsidiary, for an aggregate value not exceeding ₹60,00,00,000. These transactions include the sale of products and the granting of unsecured loans.
Additionally, approval is sought for transactions with Mr. Anupam Ghosh, the Managing Director, involving guarantees and property rent, with an aggregate value not exceeding ₹25,50,00,000. The company also proposes to ratify material related party transactions undertaken with Anondita Healthcare and Rubber Products India Ltd. during the previous financial year, amounting to ₹42,00,00,000.
Amendments and Remuneration
The EGM agenda includes a special resolution to amend the main object clause of the Memorandum of Association. The proposed substitution aims to expand the company's business activities to include the manufacturing of sexual wellness products, diagnostic kits, and latex-based products.
Furthermore, the Board has proposed an increase in the managerial remuneration for its Whole-time Director, Mr. Reshant Ghosh, and Managing Director, Mr. Anupam Ghosh. The remuneration for Mr. Reshant Ghosh is proposed to be revised to ₹5,00,000 per month, while Mr. Anupam Ghosh's remuneration is proposed to be increased to ₹10,00,000 per month, effective from April 1, 2026.
| Director | Proposed Monthly Remuneration |
|---|---|
| Mr. Reshant Ghosh (Whole-time Director): | ₹5,00,000 |
| Mr. Anupam Ghosh (Managing Director): | ₹10,00,000 |
The remote e-voting period will commence on May 25, 2026, and conclude on May 27, 2026.
Historical Stock Returns for Anondita Medicare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.26% | -5.64% | +12.47% | +52.65% | +223.51% | +223.51% |
How might the expansion into sexual wellness products and diagnostic kits impact Anondita Medicare's revenue mix and competitive positioning in the healthcare sector over the next 2-3 years?
What are the potential risks of concentrating the preferential warrant allotment solely with promoter Mr. Anupam Ghosh, and how could this affect minority shareholder interests if warrants are fully converted?
Given the ₹60 crore related party transaction ceiling with subsidiary Anondita Healthcare & Rubber Products, what governance mechanisms will ensure these transactions remain at arm's length and don't disadvantage the listed entity?
17
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
